Curanex Pharmaceuticals Inc (CURX)
2025-06-30 | ||||
|---|---|---|---|---|
| Other income | 403 | |||
| General & administrative | 57,658 | |||
| Total operating expenses | 57,658 | |||
| Loss from operations | -57,658 | |||
| Interest expense | 3,091 | |||
| Net loss | -60,346 | |||
| Net loss per common share basic | - | |||
| Net loss per common share diluted | - | |||
| Weighted average number of common shares outstanding basic | 24,000,000 | |||
| Weighted average number of common shares outstanding diluted | 24,000,000 | |||